BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 31391022)

  • 1. Meningococcal disease in Italy: public concern, media coverage and policy change.
    Covolo L; Croce E; Moneda M; Zanardini E; Gelatti U; Schulz PJ; Ceretti E
    BMC Public Health; 2019 Aug; 19(1):1061. PubMed ID: 31391022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact on disease incidence of a routine universal and catch-up vaccination strategy against Neisseria meningitidis C in Tuscany, Italy.
    Bechini A; Levi M; Boccalini S; Tiscione E; Balocchini E; Canessa C; Azzari C; Bonanni P
    Vaccine; 2012 Oct; 30(45):6396-401. PubMed ID: 22921931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Invasive bacterial diseases: national surveillance in Italy and vaccination coverage in the Local Health Agency 4 "Chiavarese", Liguria region (Italy).
    Trucchi C; Zoppi G
    J Prev Med Hyg; 2012 Jun; 53(2):120-4. PubMed ID: 23240174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Major infection events over 5 years: how is media coverage influencing online information needs of health care professionals and the public?
    Kostkova P; Fowler D; Wiseman S; Weinberg JR
    J Med Internet Res; 2013 Jul; 15(7):e107. PubMed ID: 23856364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Present situation and new perspectives for vaccination against Neisseria meningitidis in Tuscany, Central Italy.
    Bechini A; Levi M; Boccalini S; Tiscione E; Ceccherini V; Taddei C; Balocchini E; Bonanni P
    J Prev Med Hyg; 2012 Jun; 53(2):61-7. PubMed ID: 23240162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mass media coverage and vaccination uptake: evidence from the demand for meningococcal vaccinations in Hungary.
    Bíró A; Szabó-Morvai Á
    Eur J Health Econ; 2021 Aug; 22(6):887-903. PubMed ID: 33837470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In the Digital Era, Is Community Outrage a Feasible Proxy Indicator of Emotional Epidemiology? The Case of Meningococcal Disease in Sardinia, Italy.
    Dettori M; Arru B; Azara A; Piana A; Mariotti G; Camerada MV; Stefanelli P; Rezza G; Castiglia P
    Int J Environ Res Public Health; 2018 Jul; 15(7):. PubMed ID: 30021934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunization and media coverage in Italy: an eleven-year analysis (2007-17).
    Odone A; Tramutola V; Morgado M; Signorelli C
    Hum Vaccin Immunother; 2018; 14(10):2533-2536. PubMed ID: 29993316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emergency vaccination against epidemic meningitis in Ghana: implications for the control of meningococcal disease in West Africa.
    Woods CW; Armstrong G; Sackey SO; Tetteh C; Bugri S; Perkins BA; Rosenstein NE
    Lancet; 2000 Jan; 355(9197):30-3. PubMed ID: 10615888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased Vaccination Coverage among Adolescents and Young Adults in the District of Palermo as a Result of a Public Health Strategy to Counteract an 'Epidemic Panic'.
    Costantino C; Restivo V; Ventura G; D'Angelo C; Randazzo MA; Casuccio N; Palermo M; Casuccio A; Vitale F
    Int J Environ Res Public Health; 2018 May; 15(5):. PubMed ID: 29772848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MATS: Global coverage estimates for 4CMenB, a novel multicomponent meningococcal B vaccine.
    Medini D; Stella M; Wassil J
    Vaccine; 2015 May; 33(23):2629-36. PubMed ID: 25882169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meningococcal disease and vaccination: Knowledge and acceptability among adolescents in Italy.
    Pelullo CP; Napolitano F; Di Giuseppe G
    Hum Vaccin Immunother; 2018 May; 14(5):1197-1202. PubMed ID: 29452028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. WHO position paper, Meningococcal A conjugate vaccine: Updated guidance, February 2015.
    World Health Organization
    Vaccine; 2018 Jun; 36(24):3421-3422. PubMed ID: 28760613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meningococcal disease from the public health policy perspective.
    Black SB; Plotkin SA
    Vaccine; 2012 May; 30 Suppl 2():B37-9. PubMed ID: 22607897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The meningococcal vaccine--public policy and individual choices.
    Offit PA; Peter G
    N Engl J Med; 2003 Dec; 349(24):2353-6. PubMed ID: 14668463
    [No Abstract]   [Full Text] [Related]  

  • 16. Public policy for meningococcal vaccination.
    Cameron JC
    Hum Vaccin Immunother; 2018 May; 14(5):1216-1217. PubMed ID: 29194013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccination campaign against meningococcal disease in army recruits in Italy.
    Stroffolini T
    Epidemiol Infect; 1990 Dec; 105(3):579-83. PubMed ID: 2249722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of invasive diseases: strategies to increase vaccination coverage in children and adolescents.
    Zoppi G; Trucchi C
    J Prev Med Hyg; 2012 Jun; 53(2):125-9. PubMed ID: 23240175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of vaccination programs against measles, varicella and meningococcus C in Italy and in Tuscany and public health policies in the last decades.
    Bechini A; Chellini M; Pellegrino E; Tiscione E; Lorini C; Bonaccorsi G; Bonanni P; Boccalini S
    J Prev Med Hyg; 2018 Jun; 59(2):E120-E127. PubMed ID: 30083618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. History of Meningococcal Outbreaks in the United States: Implications for Vaccination and Disease Prevention.
    Atkinson B; Gandhi A; Balmer P
    Pharmacotherapy; 2016 Aug; 36(8):880-92. PubMed ID: 27332671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.